NEW YORK (Reuters) - Johnson & Johnson plans to start testing its experimental COVID-19 vaccine in youths aged 12 to 18 as soon as possible, and the company's previous experience with the same technology in a vaccine successfully used in children could give it a leg up with regulators.
from Latest News https://ift.tt/37XK4c8
Friday, 30 October 2020
J&J plans to test Covid-19 vaccine in ages 12-18, younger ages to follow
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment